Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Sell
4
AVTX Quote, Financials, Valuation and Earnings
Last price:
$4.59
Seasonality move
:
-21.62%
Day range:
$5.02 - $5.44
52-week range:
$5.00 - $18.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.30x
P/B ratio:
0.41x
Volume:
64.6K
Avg. volume:
86.6K
1-year change:
-64.78%
Market cap:
$54.4M
Revenue:
$441K
EPS (TTM):
-$3,523.99
AVTX Analysts' Consensus Rating
The 6 analysts providing 12-month price projections for Avalo Therapeutics shares anticipate an average target of $31.33, ranging from a low estimate of $18.00 to a high estimate of $48.00. This average target implies a growth of 514.38% compared to the current stock price of $5.10.
Consensus Price Target
$31.33
Highest Price Target
$48.00
Lowest Price Target
$18.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 1 | 5 | 5 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Leans Bullish | Buy | Buy |
AVTX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Down 50%, Is Dell Technologies a Buy?
Dell (NYSE:DELL)’s share price has been on a roller coaster…
Stock Ideas
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
33
BULZ alert for Apr 10
MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 15.35% over the past day.
Sell
31
TECS alert for Apr 10
Direxion Daily Technology Bear 3x Shares [TECS] is up 12.66% over the past day.
Sell
48
FNGA alert for Apr 10
MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 13.3% over the past day.
